IP Library Granted Patent US 8,895,720
Granted Patent B2
US 8,895,720 · App. 13/722,643 · Granted Nov 25, 2014

Nucleic acid molecules and collections thereof, their application and modification

Inventors: Ronald H. A. Plasterk (Bussum, NL); Eugene Berezikov (Vleuten, NL); Edwin Pieter Cuppen (Utrecht, NL)
Assignee: Koninklijke Nederlandse Akademie van Wetenschappen
C12N15/113C12Q2600/158C12N2310/141C12Q2600/178C12N2320/10C12Q1/6886
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,895,720
App. No.
13/722,643
Granted
Nov 25, 2014
Kind
B2
Abstract

The invention provides a method for characterising a sample comprising nucleic acid derived from a cell. The method comprises determining whether a sample comprises at least a minimal sequence of at least one new microRNA (miRNA) according to the invention or a mammalian ortholog thereof and characterizing the sample on the basis of the presence or absence of the miRNA. The invention further provides nucleic acid molecules and collections thereof and their use in therapeutic and diagnostic applications. The invention furthermore provides a method for identifying a miRNA molecule or a precursor molecule thereof.

Claims (12)

1. An isolated nucleic acid molecule, wherein said nucleic acid molecule is a miRNA, a pre-miRNA or a DNA molecule encoding said pre-miRNA, which has a length of 18-26 nucleotides in the case of miRNA, wherein:

(a) the sequence of the nucleic acid molecule comprises SEQ ID NO:11390 or its corresponding ribonucleotide sequence, or

(b) the sequence of the nucleic acid molecule has at least 90% identity over 20 consecutive nucleotides with the miRNA sequence of (a),

wherein said sequence comprises at least one modification selected from the group consisting of: a nucleotide analogue, a peptide nucleic acid a locked nucleic acid a backbone modified ribonucleotide or deoxyribonucleotide and a sugar modified ribonucleotide or deoxyribonucleotide.

2. The nucleic acid molecule of claim 1 which is a miRNA molecule.

3. The nucleic acid molecule of claim 2 , the length of which is from 18 to 26 nucleotides.

4. The nucleic acid molecule of claim 1 , wherein the nucleic acid molecule is the pre-miRNA or the DNA molecule coding therefore.

5. The nucleic acid molecule of claim 1 , that is single-stranded.

6. The nucleic acid molecule of claim 1 , that is at least partially double-stranded.

7. The nucleic acid molecule claim 1 , that is RNA, DNA, or a combination thereof.

8. A composition comprising as an active agent, a nucleic acid molecule according to claim 1 .

9. The nucleic acid molecule of claim 1 , that comprises SEQ ID NO:11390.

Continuity (2)
Division 12087649
Related Publication 20130178387A1 · Jul 11, 2013